Maximum quantity allowed is 999
请选择数量
CAS RN: 123447-62-1 | 產品號碼: P2058
產品號碼 | P2058 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__2__1H__2__0FN__3O__6S = 461.46 |
外觀與形狀(20°C) | Solid |
儲存條件 | Frozen (<0°C) |
應避免的情況 | Light Sensitive,Heat Sensitive |
包裝和容器 | 1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 123447-62-1 |
Reaxys-RN | 5894071 |
PubChem Substance ID | 253660145 |
Merck Index(14) | 7908 |
MDL編號 | MFCD00864847 |
產品規格
Appearance | Light orange to Yellow to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
性質
熔點 | 220 °C(dec.) |
Maximum Wavelength | 276 nm (H__2O) |
水溶性 | Insoluble |
溶解性(可溶於) | Dimethylformamide |
溶解性(不溶於) | Ether |
GHS
相關法規
RTECS # | XJ0600000 |
運輸資料
HS編碼* | 2941.90-000 |
Application
A Broad-Spectrum Fluoroquinolone Antibacterial Agent, Prulifloxacin
Prulifloxacin (PUFX), the prodrug of ulifloxacin (NM394), is a broad-spectrum fluoroquinolone antibacterial agent. After absorption, prulifloxacin is metabolized by esterases to ulifloxacin. Ulifloxacin, the active form of prulifloxacin, is generally more active than other fluoroquinolones against a variety of Gram-positive and Gram-negative bacteria including Pseudomonas aeruginosa.
References
- Prulifloxacin
- Pharmacologic characteristics of prulifloxacin
- Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study
- Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent
- K. Tougou, A. Nakamura, S. Watanabe, Y. Okuyama, A. Morino, Drug Metab. Dispos. 1998, 26, 355.
- Comparative assessment of prulifloxacin, sparfloxacin, gatifloxacin and levofloxacin in the rabbit model of proarrhythmia
考研文獻
文章/手冊
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。